~18 spots leftby Aug 2025

Coordinated Specialty Care for Psychosis

(AC-EPINET Trial)

Recruiting at 6 trial locations
AB
Overseen byAlan Breier
Age: < 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Indiana University
Disqualifiers: IQ < 70
Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

The investigators propose to examine the effects of CSC services delivered via TH (CSC-TH) versus the standard clinic-based CSC model (CSC-SD) on engagement and outcomes in a 12-month, randomized trial.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Coordinated Specialty Care (CSC) for First Episode Psychosis (FEP)?

Research shows that Coordinated Specialty Care (CSC) is an effective treatment for people experiencing their first episode of psychosis. It helps improve recovery and quality of life by providing group, individual, and family therapies that focus on understanding and coping with psychosis, as well as building skills like problem-solving and communication.12345

Is Coordinated Specialty Care for psychosis safe for humans?

The research articles reviewed do not provide specific safety data for Coordinated Specialty Care (CSC) for psychosis, but they do indicate that CSC is a widely accepted and standard practice for treating first-episode psychosis, suggesting it is generally considered safe.23456

How is the treatment Coordinated Specialty Care (CSC) for psychosis different from other treatments?

Coordinated Specialty Care (CSC) is unique because it is a team-based approach that combines group, individual, and family therapies to help people with early psychosis. It focuses on building a supportive relationship, recovery, education, and skills training to improve quality of life and help patients achieve personal goals.23457

Research Team

AB

Alan Breier

Principal Investigator

Indiana Univeristy

Eligibility Criteria

This trial is for young individuals aged 16-35 who have recently been diagnosed with certain mental health conditions, including schizophrenia and bipolar disorder with psychotic features. Participants must be new to one of the six clinical programs, able to consent, and commit to the study schedule.

Inclusion Criteria

I am between 16 and 35 years old.
New intakes enrolled in one of the six clinical programs
Able to give informed consent
See 2 more

Exclusion Criteria

Known IQ < 70 based on participant report

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either telehealth-based or standard clinic-based CSC model treatment for 12 months

12 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Coordinated Specialty Care (CSC) (Behavioural Intervention)
Trial OverviewThe study compares two ways of delivering Coordinated Specialty Care (CSC) for mental health: through telehealth (CSC-TH) versus standard in-clinic care (CSC-SD). The goal is to see which method keeps patients more engaged over a year.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: CSC-THExperimental Treatment1 Intervention
Telehealth based CSC model treatment. Treatment will be delivered largely through telehealth for 12 months.
Group II: CSC-SDPlacebo Group1 Intervention
Standard clinic-based CSC model treatment. Treatment will be delivered largely in clinic for 12 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

Vanderbilt University

Collaborator

Trials
714
Recruited
6,143,000+

University of Rochester

Collaborator

Trials
883
Recruited
555,000+

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

Yale University

Collaborator

Trials
1,963
Recruited
3,046,000+

Ohio State University

Collaborator

Trials
891
Recruited
2,659,000+

Tulane University

Collaborator

Trials
129
Recruited
259,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+

Findings from Research

A machine-learning prediction tool was developed to forecast education and work outcomes for individuals aged 16 to 30 with first-episode psychosis, showing strong predictive accuracy with AUCs ranging from 0.68 to 0.88 for one-year trajectories.
While the tool effectively predicts education/work status, it struggled with forecasting psychiatric hospitalizations beyond three months, indicating a need for further development in this area before clinical application.
Prediction Tool for Individual Outcome Trajectories Across the Next Year in First-Episode Psychosis in Coordinated Specialty Care.Basaraba, CN., Scodes, JM., Dambreville, R., et al.[2023]
A study of 6,246 individuals with first-episode psychosis over an average follow-up of 4.24 years revealed significant gaps in the delivery of coordinated specialty care (CSC), particularly in the use and monitoring of antipsychotic medications.
Key quality indicators showed that inadequate monitoring for smoking and lack of integrated care were strongly linked to higher rates of psychiatric hospitalization, indicating that improvements in these areas are crucial for better patient outcomes.
Using Claims Data to Assess Treatment Quality of First-Episode Psychosis.Reist, C., Valdes, E., Ren, Y., et al.[2021]
Coordinated specialty care (CSC) is an evidence-based approach for treating individuals experiencing their first episode of psychosis, focusing on therapies that support both the client and their family.
The CSC model emphasizes building a therapeutic alliance and includes education and skills training to enhance recovery, improve quality of life, and help clients achieve their personal goals.
Evidence-Based Psychosocial Treatment for Individuals with Early Psychosis.Wright, A., Browne, J., Mueser, KT., et al.[2021]

References

Prediction Tool for Individual Outcome Trajectories Across the Next Year in First-Episode Psychosis in Coordinated Specialty Care. [2023]
Using Claims Data to Assess Treatment Quality of First-Episode Psychosis. [2021]
Evidence-Based Psychosocial Treatment for Individuals with Early Psychosis. [2021]
Implementing Coordinated Specialty Care for First Episode Psychosis: A Review of Barriers and Solutions. [2021]
Policy Complexities in Financing First Episode Psychosis Services: Implementation Realities from a Home Rule State. [2023]
Pennsylvania coordinated specialty care programs for first-episode psychosis: 6- and 12-month outcomes. [2021]
Community- and Program-Level Predictors of Funding Streams Used by Coordinated Specialty Care Programs. [2023]